Merck"s Joseph Romanelli to Speak at Bank of America Healthcare Conference

Merck & Co., known as MSD outside the U.S. and Canada, announced that Joseph Romanelli, the president of Human Health International, will participate in a fireside chat at the Bank of America 2024 Global Healthcare Conference. This event is scheduled for September 18, 2024, at 6:40 a.m. EDT / 11:40 a.m. BST. Investors, analysts, media representatives, and the general public are invited to listen to the live audio webcast of the presentation, which will be accessible through a provided weblink. The participation of Joseph Romanelli highlights Merck's commitment to engaging with stakeholders in the healthcare sector. The conference serves as a platform for discussing advancements in healthcare and the pharmaceutical industry, as well as Merck's ongoing initiatives and strategies. This engagement is crucial for maintaining transparency and fostering relationships with investors and the public. Merck is dedicated to using leading-edge science to improve lives globally, emphasizing a diverse and inclusive workforce. The company operates with a focus on sustainability and responsibility, aiming to create a healthy future for communities worldwide. This commitment is reflected in their ongoing research and development efforts. The announcement also includes a forward-looking statement, indicating that the company's management's beliefs and expectations are subject to risks and uncertainties. These factors could impact the actual results, highlighting the dynamic nature of the pharmaceutical industry and the importance of regulatory compliance and market conditions.